TY - JOUR
T1 - Recent developments in structure-activity relationships for steroid modulators of GABAA receptors
AU - Covey, Douglas F.
AU - Evers, Alex S.
AU - Mennerick, Steven
AU - Zorumski, Charles F.
AU - Purdy, Robert H.
N1 - Funding Information:
The authors’ research was supported by National Institutes of Health grants GM 47969 (D.F.C., A.S.E, C.F.Z.), MH45493 (C.F.Z.), AA 06420 (R.H.P.), a NARSAD Young Investigator Award (S.M.), a Klingenstein Foundation grant (S.M.) and a gift from the Bantly Foundation (C.F.Z.).
PY - 2001
Y1 - 2001
N2 - GABAergic neurotransmission can be both positively and negatively modulated by steroids. The steroid effects are thought to be mediated by binding of steroids to specific sites on GABAA receptors. It appears that the receptor sites for positive and negative modulatory steroids are different. Thus far, the location and number of binding sites for steroids on these receptors have not been established. In this brief review, we concentrate largely on results from our own structure-activity studies. Novel analogues have been studied to further delineate the structural features required for compounds to modulate receptor function via steroid binding sites. Non-naturally occurring enantiomers of both positive and negative modulators have been studied to provide further evidence for the existence of specific steroid binding sites on the receptors.
AB - GABAergic neurotransmission can be both positively and negatively modulated by steroids. The steroid effects are thought to be mediated by binding of steroids to specific sites on GABAA receptors. It appears that the receptor sites for positive and negative modulatory steroids are different. Thus far, the location and number of binding sites for steroids on these receptors have not been established. In this brief review, we concentrate largely on results from our own structure-activity studies. Novel analogues have been studied to further delineate the structural features required for compounds to modulate receptor function via steroid binding sites. Non-naturally occurring enantiomers of both positive and negative modulators have been studied to provide further evidence for the existence of specific steroid binding sites on the receptors.
KW - Benz[e]indenes
KW - Functional modulation
KW - Intravenous anesthetic
KW - Ligand gated ion channels
KW - Neuroactive steriod
KW - Neurosteroid enantiomer
UR - http://www.scopus.com/inward/record.url?scp=0035666443&partnerID=8YFLogxK
U2 - 10.1016/S0165-0173(01)00126-6
DO - 10.1016/S0165-0173(01)00126-6
M3 - Article
C2 - 11744077
AN - SCOPUS:0035666443
SN - 0165-0173
VL - 37
SP - 91
EP - 97
JO - Brain Research Reviews
JF - Brain Research Reviews
IS - 1-3
ER -